Researchers Discover New Vulnerability in Deadly Form of Lung Cancer

Video   Jul 04, 2018 | UT Southwestern, YouTube

 

Researchers at the Children’s Medical Center Research Institute at UT Southwestern (CRI) have discovered a new metabolic vulnerability in small cell lung cancer (SCLC) that can be targeted by existing drug therapies.

SCLC is a deadly and aggressive form of lung cancer with few therapeutic options and an incredibly low five-year survival rate of 5 percent. Researchers at CRI believe the key to finding new therapies for this disease lies in better understanding the metabolism of SCLC.

This content has been republished from materials provided by UT Southwestern. Note: material may have been edited for length and content. For further information, please contact the cited source.

 
More Information
 
 
 

Recommended Videos

Pill for Better Diagnosis of Breast Cancer

Video

Researchers from the University of Michigan have developed a diagnostic imaging pill enabling the early and more accurate diagnosis of cancerous tumors in breast tissue.

WATCH NOW

CellStream™ Benchtop Flow Cytometer for Sensitive Cell Analysis

Video

The new CellStream™ benchtop flow cytometer delivers unparalleled sensitivity and flexibility for cell and particle analysis.

WATCH NOW

New Pressure Controller Solution: LineUP™ Series

Video

Fluigent LineUP™ Series is a complete solution for using air pressure to drive fluid flow with the highest flexibility and ease of use.

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy